subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "520"
part_subject: "ORAL DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "520.816"
section_subject: "Epsiprantel."
cfr_reference: "21 CFR 520.816"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Each tablet contains either 12.5, 25, 50, or 100 milligrams of epsiprantel.
(b)Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c)Conditions of use—(1) Dogs—(i) Amount. 2.5 milligrams per pound of body weight.
(ii)Indications for use. Removal of canine cestodes Dipylidium caninum and Taenia pisiformis.
(2)Cats—(i) Amount. 1.25 milligrams per pound of body weight.
(ii)Indications for use. Removal of feline cestodes D.
caninum and T.
taeniaeformis.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.